Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Microbiota-derived lantibiotic restores resistance against vancomycin-resistant Enterococcus.

Kim SG, Becattini S, Moody TU, Shliaha PV, Littmann ER, Seok R, Gjonbalaj M, Eaton V, Fontana E, Amoretti L, Wright R, Caballero S, Wang ZX, Jung HJ, Morjaria SM, Leiner IM, Qin W, Ramos RJJF, Cross JR, Narushima S, Honda K, Peled JU, Hendrickson RC, Taur Y, van den Brink MRM, Pamer EG.

Nature. 2019 Aug;572(7771):665-669. doi: 10.1038/s41586-019-1501-z. Epub 2019 Aug 21.

PMID:
31435014
2.

Minimal residual disease negativity in multiple myeloma is associated with intestinal microbiota composition.

Pianko MJ, Devlin SM, Littmann ER, Chansakul A, Mastey D, Salcedo M, Fontana E, Ling L, Tavitian E, Slingerland JB, Slingerland AE, Clurman A, Gomes ALC, Taur Y, Pamer EG, Peled JU, van den Brink MRM, Landgren O, Lesokhin AM.

Blood Adv. 2019 Jul 9;3(13):2040-2044. doi: 10.1182/bloodadvances.2019032276.

3.

Antibiotic-Induced Shifts in Fecal Microbiota Density and Composition during Hematopoietic Stem Cell Transplantation.

Morjaria S, Schluter J, Taylor BP, Littmann ER, Carter RA, Fontana E, Peled JU, van den Brink MRM, Xavier JB, Taur Y.

Infect Immun. 2019 Aug 21;87(9). pii: e00206-19. doi: 10.1128/IAI.00206-19. Print 2019 Sep.

4.

Diversification and Evolution of Vancomycin-Resistant Enterococcus faecium during Intestinal Domination.

Dubin KA, Mathur D, McKenney PT, Taylor BP, Littmann ER, Peled JU, van den Brink MRM, Taur Y, Pamer EG, Xavier JB.

Infect Immun. 2019 Jun 20;87(7). pii: e00102-19. doi: 10.1128/IAI.00102-19. Print 2019 Jul.

5.

Engineering High- k/SiGe Interface with ALD Oxide for Selective GeO x Reduction.

Kavrik MS, Ercius P, Cheung J, Tang K, Wang Q, Fruhberger B, Kim M, Taur Y, McIntyre PC, Kummel AC.

ACS Appl Mater Interfaces. 2019 Apr 24;11(16):15111-15121. doi: 10.1021/acsami.8b22362. Epub 2019 Apr 15.

PMID:
30938163
6.

Genome-Wide Screening for Enteric Colonization Factors in Carbapenem-Resistant ST258 Klebsiella pneumoniae.

Jung HJ, Littmann ER, Seok R, Leiner IM, Taur Y, Peled J, van den Brink M, Ling L, Chen L, Kreiswirth BN, Goodman AL, Pamer EG.

MBio. 2019 Mar 12;10(2). pii: e02663-18. doi: 10.1128/mBio.02663-18.

7.

Inhibiting antibiotic-resistant Enterobacteriaceae by microbiota-mediated intracellular acidification.

Sorbara MT, Dubin K, Littmann ER, Moody TU, Fontana E, Seok R, Leiner IM, Taur Y, Peled JU, van den Brink MRM, Litvak Y, Bäumler AJ, Chaubard JL, Pickard AJ, Cross JR, Pamer EG.

J Exp Med. 2019 Jan 7;216(1):84-98. doi: 10.1084/jem.20181639. Epub 2018 Dec 18.

8.

Reconstitution of the gut microbiota of antibiotic-treated patients by autologous fecal microbiota transplant.

Taur Y, Coyte K, Schluter J, Robilotti E, Figueroa C, Gjonbalaj M, Littmann ER, Ling L, Miller L, Gyaltshen Y, Fontana E, Morjaria S, Gyurkocza B, Perales MA, Castro-Malaspina H, Tamari R, Ponce D, Koehne G, Barker J, Jakubowski A, Papadopoulos E, Dahi P, Sauter C, Shaffer B, Young JW, Peled J, Meagher RC, Jenq RR, van den Brink MRM, Giralt SA, Pamer EG, Xavier JB.

Sci Transl Med. 2018 Sep 26;10(460). pii: eaap9489. doi: 10.1126/scitranslmed.aap9489.

9.

Ultralow Defect Density at Sub-0.5 nm HfO2/SiGe Interfaces via Selective Oxygen Scavenging.

Kavrik MS, Thomson E, Chagarov E, Tang K, Ueda ST, Hou V, Aoki T, Kim M, Fruhberger B, Taur Y, McIntyre PC, Kummel AC.

ACS Appl Mater Interfaces. 2018 Sep 12;10(36):30794-30802. doi: 10.1021/acsami.8b06547. Epub 2018 Aug 27.

PMID:
30073827
10.

Gut microbiota dysbiosis and diarrhea in kidney transplant recipients.

Lee JR, Magruder M, Zhang L, Westblade LF, Satlin MJ, Robertson A, Edusei E, Crawford C, Ling L, Taur Y, Schluter J, Lubetzky M, Dadhania D, Pamer E, Suthanthiran M.

Am J Transplant. 2019 Feb;19(2):488-500. doi: 10.1111/ajt.14974. Epub 2018 Jul 21.

PMID:
29920927
11.

The Perils of Multiplex Gastrointestinal Pathogen Panels: Pseudo-outbreaks of Salmonellae and Entamoeba histolytica in Immunocompromised Hosts.

Robilotti E, Powell E, Usiak S, Taur Y, Babady NE, Kamboj M.

Infect Control Hosp Epidemiol. 2018 Jul;39(7):867-870. doi: 10.1017/ice.2018.95. Epub 2018 May 10.

PMID:
29743127
12.

Distinctive Infectious Complications in Patients with Central Nervous System Lymphoma Undergoing Thiotepa, Busulfan, and Cyclophosphamide-conditioned Autologous Stem Cell Transplantation.

Scordo M, Morjaria SM, Littmann ER, Bhatia A, Chung HH, Maloy M, DeAngelis LM, Giralt SA, Taur Y, Sauter CS.

Biol Blood Marrow Transplant. 2018 Sep;24(9):1914-1919. doi: 10.1016/j.bbmt.2018.04.013. Epub 2018 Apr 18.

13.

Impact of gut colonization with butyrate-producing microbiota on respiratory viral infection following allo-HCT.

Haak BW, Littmann ER, Chaubard JL, Pickard AJ, Fontana E, Adhi F, Gyaltshen Y, Ling L, Morjaria SM, Peled JU, van den Brink MR, Geyer AI, Cross JR, Pamer EG, Taur Y.

Blood. 2018 Jun 28;131(26):2978-2986. doi: 10.1182/blood-2018-01-828996. Epub 2018 Apr 19.

14.

Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity.

DeFilipp Z, Peled JU, Li S, Mahabamunuge J, Dagher Z, Slingerland AE, Del Rio C, Valles B, Kempner ME, Smith M, Brown J, Dey BR, El-Jawahri A, McAfee SL, Spitzer TR, Ballen KK, Sung AD, Dalton TE, Messina JA, Dettmer K, Liebisch G, Oefner P, Taur Y, Pamer EG, Holler E, Mansour MK, van den Brink MRM, Hohmann E, Jenq RR, Chen YB.

Blood Adv. 2018 Apr 10;2(7):745-753. doi: 10.1182/bloodadvances.2018017731.

15.

Serious Infections in Patients Receiving Ibrutinib for Treatment of Lymphoid Cancer.

Varughese T, Taur Y, Cohen N, Palomba ML, Seo SK, Hohl TM, Redelman-Sidi G.

Clin Infect Dis. 2018 Aug 16;67(5):687-692. doi: 10.1093/cid/ciy175.

16.

Cytokine Release Syndrome Grade as a Predictive Marker for Infections in Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia Treated With Chimeric Antigen Receptor T Cells.

Park JH, Romero FA, Taur Y, Sadelain M, Brentjens RJ, Hohl TM, Seo SK.

Clin Infect Dis. 2018 Aug 1;67(4):533-540. doi: 10.1093/cid/ciy152.

17.

A Case of Adult Intestinal Toxemia Botulism During Prolonged Hospitalization in an Allogeneic Hematopoietic Cell Transplant Recipient.

Parameswaran L, Rao A, Chastain K, Ackelsburg J, Adams E, Jackson B, Voigt LP, Chen X, Boulad F, Taur Y.

Clin Infect Dis. 2017 Dec 27;66(suppl_1):S99-S102. doi: 10.1093/cid/cix847.

PMID:
29293935
18.

Antibiotic treatment for Tuberculosis induces a profound dysbiosis of the microbiome that persists long after therapy is completed.

Wipperman MF, Fitzgerald DW, Juste MAJ, Taur Y, Namasivayam S, Sher A, Bean JM, Bucci V, Glickman MS.

Sci Rep. 2017 Sep 7;7(1):10767. doi: 10.1038/s41598-017-10346-6.

19.

Pathogenicity Locus, Core Genome, and Accessory Gene Contributions to Clostridium difficile Virulence.

Lewis BB, Carter RA, Ling L, Leiner I, Taur Y, Kamboj M, Dubberke ER, Xavier J, Pamer EG.

MBio. 2017 Aug 8;8(4). pii: e00885-17. doi: 10.1128/mBio.00885-17.

20.

Commensal microbes provide first line defense against Listeria monocytogenes infection.

Becattini S, Littmann ER, Carter RA, Kim SG, Morjaria SM, Ling L, Gyaltshen Y, Fontana E, Taur Y, Leiner IM, Pamer EG.

J Exp Med. 2017 Jul 3;214(7):1973-1989. doi: 10.1084/jem.20170495. Epub 2017 Jun 6.

21.

Protective Factors in the Intestinal Microbiome Against Clostridium difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation.

Lee YJ, Arguello ES, Jenq RR, Littmann E, Kim GJ, Miller LC, Ling L, Figueroa C, Robilotti E, Perales MA, Barker JN, Giralt S, van den Brink MRM, Pamer EG, Taur Y.

J Infect Dis. 2017 Apr 1;215(7):1117-1123. doi: 10.1093/infdis/jix011.

22.

Intestinal Microbiota and Relapse After Hematopoietic-Cell Transplantation.

Peled JU, Devlin SM, Staffas A, Lumish M, Khanin R, Littmann ER, Ling L, Kosuri S, Maloy M, Slingerland JB, Ahr KF, Porosnicu Rodriguez KA, Shono Y, Slingerland AE, Docampo MD, Sung AD, Weber D, Alousi AM, Gyurkocza B, Ponce DM, Barker JN, Perales MA, Giralt SA, Taur Y, Pamer EG, Jenq RR, van den Brink MRM.

J Clin Oncol. 2017 May 20;35(15):1650-1659. doi: 10.1200/JCO.2016.70.3348. Epub 2017 Mar 15.

23.

Microbiota Disruption Induced by Early Use of Broad-Spectrum Antibiotics Is an Independent Risk Factor of Outcome after Allogeneic Stem Cell Transplantation.

Weber D, Jenq RR, Peled JU, Taur Y, Hiergeist A, Koestler J, Dettmer K, Weber M, Wolff D, Hahn J, Pamer EG, Herr W, Gessner A, Oefner PJ, van den Brink MRM, Holler E.

Biol Blood Marrow Transplant. 2017 May;23(5):845-852. doi: 10.1016/j.bbmt.2017.02.006. Epub 2017 Feb 14.

24.

Gut Microbiota and Autism: Key Concepts and Findings.

Ding HT, Taur Y, Walkup JT.

J Autism Dev Disord. 2017 Feb;47(2):480-489. doi: 10.1007/s10803-016-2960-9. Review.

PMID:
27882443
25.
26.

Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice.

Shono Y, Docampo MD, Peled JU, Perobelli SM, Velardi E, Tsai JJ, Slingerland AE, Smith OM, Young LF, Gupta J, Lieberman SR, Jay HV, Ahr KF, Porosnicu Rodriguez KA, Xu K, Calarfiore M, Poeck H, Caballero S, Devlin SM, Rapaport F, Dudakov JA, Hanash AM, Gyurkocza B, Murphy GF, Gomes C, Liu C, Moss EL, Falconer SB, Bhatt AS, Taur Y, Pamer EG, van den Brink MRM, Jenq RR.

Sci Transl Med. 2016 May 18;8(339):339ra71. doi: 10.1126/scitranslmed.aaf2311.

27.

Antibiotic-Induced Changes in the Intestinal Microbiota and Disease.

Becattini S, Taur Y, Pamer EG.

Trends Mol Med. 2016 Jun;22(6):458-478. doi: 10.1016/j.molmed.2016.04.003. Epub 2016 May 10. Review.

28.

Toxoplasma Encephalitis in Atypical Hosts at an Academic Cancer Center.

Morjaria S, Epstein DJ, Romero FA, Taur Y, Seo SK, Papanicolaou GA, Hatzoglou V, Rosenblum M, Perales MA, Scordo M, Kaltsas A.

Open Forum Infect Dis. 2016 Mar 30;3(2):ofw070. doi: 10.1093/ofid/ofw070. eCollection 2016 Mar.

29.

Microbiome mediation of infections in the cancer setting.

Taur Y, Pamer EG.

Genome Med. 2016 Apr 18;8(1):40. doi: 10.1186/s13073-016-0306-z. Review.

30.

Gut Microbiota Predict Pulmonary Infiltrates after Allogeneic Hematopoietic Cell Transplantation.

Harris B, Morjaria SM, Littmann ER, Geyer AI, Stover DE, Barker JN, Giralt SA, Taur Y, Pamer EG.

Am J Respir Crit Care Med. 2016 Aug 15;194(4):450-63. doi: 10.1164/rccm.201507-1491OC.

31.

Role of intestinal microbiota in transplantation outcomes.

Taur Y, Jenq RR, Ubeda C, van den Brink M, Pamer EG.

Best Pract Res Clin Haematol. 2015 Jun-Sep;28(2-3):155-61. doi: 10.1016/j.beha.2015.10.013. Epub 2015 Oct 22. Review.

32.

West Nile Virus Central Nervous System Infection in Patients Treated With Rituximab: Implications for Diagnosis and Prognosis, With a Review of Literature.

Morjaria S, Arguello E, Taur Y, Sepkowitz K, Hatzoglou V, Nemade A, Rosenblum M, Cavalcanti MS, Palomba ML, Kaltsas A.

Open Forum Infect Dis. 2015 Sep 19;2(4):ofv136. doi: 10.1093/ofid/ofv136. eCollection 2015 Dec.

33.

Transmission of Clostridium difficile During Hospitalization for Allogeneic Stem Cell Transplant.

Kamboj M, Sheahan A, Sun J, Taur Y, Robilotti E, Babady E, Papanicolaou G, Jakubowski A, Pamer E, Sepkowitz K.

Infect Control Hosp Epidemiol. 2016 Jan;37(1):8-15. doi: 10.1017/ice.2015.237. Epub 2015 Oct 21.

34.

Effect of Perioperative β-Blockers on Pulmonary Complications among Patients with Chronic Obstructive Pulmonary Disease Undergoing Lung Resection Surgery.

Kamath A, Stover DE, Hemdan A, Belinskaya I, Steingart RM, Taur Y, Feinstein MB.

Lung Cancer Int. 2015;2015:204826. doi: 10.1155/2015/204826. Epub 2015 Sep 1.

35.

Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease.

Jenq RR, Taur Y, Devlin SM, Ponce DM, Goldberg JD, Ahr KF, Littmann ER, Ling L, Gobourne AC, Miller LC, Docampo MD, Peled JU, Arpaia N, Cross JR, Peets TK, Lumish MA, Shono Y, Dudakov JA, Poeck H, Hanash AM, Barker JN, Perales MA, Giralt SA, Pamer EG, van den Brink MR.

Biol Blood Marrow Transplant. 2015 Aug;21(8):1373-83. doi: 10.1016/j.bbmt.2015.04.016. Epub 2015 May 11.

36.

Gut microbiota and tacrolimus dosing in kidney transplantation.

Lee JR, Muthukumar T, Dadhania D, Taur Y, Jenq RR, Toussaint NC, Ling L, Pamer E, Suthanthiran M.

PLoS One. 2015 Mar 27;10(3):e0122399. doi: 10.1371/journal.pone.0122399. eCollection 2015.

37.

A comparison of the pathological, clinical and radiographical, features of cryptogenic organising pneumonia, acute fibrinous and organising pneumonia and granulomatous organising pneumonia.

Feinstein MB, DeSouza SA, Moreira AL, Stover DE, Heelan RT, Iyriboz TA, Taur Y, Travis WD.

J Clin Pathol. 2015 Jun;68(6):441-7. doi: 10.1136/jclinpath-2014-202626. Epub 2015 Mar 5. Erratum in: J Clin Pathol. 2015 Jul;68(7):e2.

PMID:
25742910
38.

Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile.

Buffie CG, Bucci V, Stein RR, McKenney PT, Ling L, Gobourne A, No D, Liu H, Kinnebrew M, Viale A, Littmann E, van den Brink MR, Jenq RR, Taur Y, Sander C, Cross JR, Toussaint NC, Xavier JB, Pamer EG.

Nature. 2015 Jan 8;517(7533):205-8. doi: 10.1038/nature13828. Epub 2014 Oct 22.

39.

The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation.

Taur Y, Jenq RR, Perales MA, Littmann ER, Morjaria S, Ling L, No D, Gobourne A, Viale A, Dahi PB, Ponce DM, Barker JN, Giralt S, van den Brink M, Pamer EG.

Blood. 2014 Aug 14;124(7):1174-82. doi: 10.1182/blood-2014-02-554725. Epub 2014 Jun 17.

40.

Tolerability of chemotherapy in HIV-infected women with breast cancer: are there prognostic implications?

Parameswaran L, Taur Y, Shah MK, Traina TA, Seo SK.

AIDS Patient Care STDS. 2014 Jul;28(7):358-64. doi: 10.1089/apc.2013.0370. Epub 2014 May 19.

PMID:
24839993
41.

Early Clostridium difficile infection during allogeneic hematopoietic stem cell transplantation.

Kinnebrew MA, Lee YJ, Jenq RR, Lipuma L, Littmann ER, Gobourne A, No D, van den Brink M, Pamer EG, Taur Y.

PLoS One. 2014 Mar 24;9(3):e90158. doi: 10.1371/journal.pone.0090158. eCollection 2014.

42.

Harnessing microbiota to kill a pathogen: Fixing the microbiota to treat Clostridium difficile infections.

Taur Y, Pamer EG.

Nat Med. 2014 Mar;20(3):246-7. doi: 10.1038/nm.3492. No abstract available.

43.

Diameter-independent hole mobility in Ge/Si core/shell nanowire field effect transistors.

Nguyen BM, Taur Y, Picraux ST, Dayeh SA.

Nano Lett. 2014 Feb 12;14(2):585-91. doi: 10.1021/nl4037559. Epub 2014 Jan 6.

PMID:
24382113
44.

The impact of repeat biopsies on infectious complications in men with prostate cancer on active surveillance.

Ehdaie B, Vertosick E, Spaliviero M, Giallo-Uvino A, Taur Y, O'Sullivan M, Livingston J, Sogani P, Eastham J, Scardino P, Touijer K.

J Urol. 2014 Mar;191(3):660-4. doi: 10.1016/j.juro.2013.08.088. Epub 2013 Sep 7.

PMID:
24018237
45.

The intestinal microbiota and susceptibility to infection in immunocompromised patients.

Taur Y, Pamer EG.

Curr Opin Infect Dis. 2013 Aug;26(4):332-7. doi: 10.1097/QCO.0b013e3283630dd3. Review.

46.

International travel patterns and travel risks of patients diagnosed with cancer.

Mikati T, Taur Y, Seo SK, Shah MK.

J Travel Med. 2013 Mar-Apr;20(2):71-7. doi: 10.1111/jtm.12013. Epub 2013 Jan 30.

47.

Intestinal microbiota containing Barnesiella species cures vancomycin-resistant Enterococcus faecium colonization.

Ubeda C, Bucci V, Caballero S, Djukovic A, Toussaint NC, Equinda M, Lipuma L, Ling L, Gobourne A, No D, Taur Y, Jenq RR, van den Brink MR, Xavier JB, Pamer EG.

Infect Immun. 2013 Mar;81(3):965-73. doi: 10.1128/IAI.01197-12. Epub 2013 Jan 14.

48.

Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation.

Taur Y, Xavier JB, Lipuma L, Ubeda C, Goldberg J, Gobourne A, Lee YJ, Dubin KA, Socci ND, Viale A, Perales MA, Jenq RR, van den Brink MR, Pamer EG.

Clin Infect Dis. 2012 Oct;55(7):905-14. doi: 10.1093/cid/cis580. Epub 2012 Jun 20.

49.

Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation.

Jenq RR, Ubeda C, Taur Y, Menezes CC, Khanin R, Dudakov JA, Liu C, West ML, Singer NV, Equinda MJ, Gobourne A, Lipuma L, Young LF, Smith OM, Ghosh A, Hanash AM, Goldberg JD, Aoyama K, Blazar BR, Pamer EG, van den Brink MR.

J Exp Med. 2012 May 7;209(5):903-11. doi: 10.1084/jem.20112408. Epub 2012 Apr 30.

50.

Evaluation of programmatic changes to an antimicrobial stewardship program with house officer feedback.

Hong SY, Epstein LH, Lawrence K, Davidson L, Taur Y, Nadkarni L, Doron S.

J Eval Clin Pract. 2013 Apr;19(2):388-92. doi: 10.1111/j.1365-2753.2012.01840.x. Epub 2012 Mar 15.

Supplemental Content

Support Center